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PI3K-AKT-FoxO axis in cancer and agingAKT/Protein kinase B (PKB) had emerged during the past 20 years
as a key signaling molecule that regulates diverse cellular functions
related to metabolism, longevity and cellular senescence downstream
of tyrosine kinase receptors and PI3K. Increased AKT activity, induced
by deregulation of its upstream effectors, is observed in the majority
of human cancers and is considered a main oncogenic event. Among
the most evolutionarily conserved targets of AKT are the forkhead
box O (FoxO) transcription factors. A vital breakthrough in under-
standing AKT function came from longevity studies in C. elegans
establishing the DAF-16 transcription factor as a main mediator of
AKT signaling. Follow-up studies in mammalian systems established
a signaling cascade from AKT to the DAF-16 orthologues, the FoxO
transcription factors. Research in the past 10 years uncovered a myr-
iad of physiological roles of FoxO proteins including regulation of me-
tabolism, cell cycle and response to stress factors orchestrated
through complex FoxO regulation involving transcriptional and
post-transcriptional mechanisms. The current special review issue
provides an up-to-date review of the ﬁeld, focusing on the regulation
of FoxO transcription factors through a complex network of protein–
protein interactions, phosphorylation, acetylation and ubiquitination
and offers perspectives for future research directions.
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work in his laboratory showed that the serine/threonine
kinase Akt is the major downstream effector of growth
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